However, there is a concern of using primaquine due to the haemolysis associated with the drug in Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency individuals [12]. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.